Clinical and genetic features of eight Chinese autosomal-dominant optic atrophy pedigrees with six novel OPA1 pathogenic variants

References

• Fraser JA, Biousse V, Newman NJ. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55(4):299–334. doi:10.1016/j.survophthal.2009.10.002.
   PubMed Web of Science ®Google Scholar
• Kjer B, Eiberg H, Kjer P, Rosenberg T. Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects. Acta Ophthalmol Scand. 1996;74(1):3–7. doi:10.1111/j.1600-0420.1996.tb00672.x.
   PubMedGoogle Scholar
• Yu-Wai-Man P, Griffiths PG, Burke A, Sellar PW, Clarke MP, Gnanaraj L, Ah-Kine D, Hudson G, Czermin B, Taylor RW, et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology. 2010;117(8):1538–1546, 1546.e1531. doi:10.1016/j.ophtha.2009.12.038.
   PubMed Web of Science ®Google Scholar
• Skidd PM, Lessell S, Cestari DM. Autosomal dominant hereditary optic neuropathy (ADOA): a review of the genetics and clinical manifestations of ADOA and ADOA+. Semin Ophthalmol. 2013;28(5–6):422–26. doi:10.3109/08820538.2013.825296.
   PubMed Web of Science ®Google Scholar
• Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo-Kottler B, Auburger G, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26(2):211–15. doi:10.1038/79944.
   PubMed Web of Science ®Google Scholar
• Kerrison JB, Arnould VJ, Ferraz Sallum JM, Vagefi MR, Barmada MM, Li Y, Zhu D, Maumenee IH. Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12.2-12.3. Arch Ophthalmol. 1999;117(6):805–10. doi:10.1001/archopht.117.6.805.
   PubMedGoogle Scholar
• Katz BJ, Zhao Y, Warner JE, Tong Z, Yang Z, Zhang K. A family with X-linked optic atrophy linked to the OPA2 locus Xp11.4-Xp11.2. Am J Med Genet A. 2006;140(20):2207–11. doi:10.1002/ajmg.a.31455.
   PubMedGoogle Scholar
• Anikster Y, Kleta R, Shaag A, Gahl WA, Type EO. III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews. Am J Hum Genet. 2001;69(6):1218–24. doi:10.1086/324651.
   PubMed Web of Science ®Google Scholar
• Carelli V, Schimpf S, Fuhrmann N, Valentino ML, Zanna C, Iommarini L, Papke M, Schaich S, Tippmann S, Baumann B, et al. A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16. Hum Mol Genet. 2011;20(10):1893–905. doi:10.1093/hmg/ddr071.
   PubMed Web of Science ®Google Scholar
• Hanein S, Perrault I, Roche O, Gerber S, Khadom N, Rio M, Boddaert N, Jean-Pierre M, Brahimi N, Serre V, et al. TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy. Am J Hum Genet. 2009;84(4):493–98. doi:10.1016/j.ajhg.2009.03.003.
   PubMed Web of Science ®Google Scholar
• Barbet F, Hakiki S, Orssaud C, Gerber S, Perrault I, Hanein S, Ducroq D, Dufier JL, Munnich A, Kaplan J, et al. A third locus for dominant optic atrophy on chromosome 22q. J Med Genet. 2005;42(1):e1. doi:10.1136/jmg.2004.025502.
   PubMed Web of Science ®Google Scholar
• Barbet F, Gerber S, Hakiki S, Perrault I, Hanein S, Ducroq D, Tanguy G, Dufier J-L, Munnich A, Rozet J-M, et al. A first locus for isolated autosomal recessive optic atrophy (ROA1) maps to chromosome 8q. Eur J Hum Genet. 2003;11(12):966–71. doi:10.1038/sj.ejhg.5201070.
   PubMed Web of Science ®Google Scholar
• Delettre C, Griffoin J-M, Kaplan J, Dollfus H, Lorenz B, Faivre L, Lenaers G, Belenguer P, Hamel CP. Mutation spectrum and splicing variants in the OPA1 gene. Hum Genet. 2001;109(6):584–91. doi:10.1007/s00439-001-0633-y.
   PubMed Web of Science ®Google Scholar
• Toomes C, Marchbank NJ, Mackey DA, Craig JE, Newbury-Ecob RA, Bennett CP, Vize CJ, Desai SP, Black GC, Patel N, et al. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet. 2001;10(13):1369–78. doi:10.1093/hmg/10.13.1369.
   PubMed Web of Science ®Google Scholar
• Ferre M, Bonneau D, Milea D, Chevrollier A, Verny C, Dollfus H, Ayuso C, Defoort S, Vignal C, Zanlonghi X, et al. Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations. Hum Mutat. 2009;30(7):E692–705. doi:10.1002/humu.v30:7.
   PubMed Web of Science ®Google Scholar
• Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26(2):207–10. doi:10.1038/79936.
   PubMed Web of Science ®Google Scholar
• Ranieri M, Brajkovic S, Riboldi G, Ronchi D, Rizzo F, Bresolin N, Corti S, Comi GP. Mitochondrial fusion proteins and human diseases. Neurol Res Int. 2013;2013:293893. doi:10.1155/2013/293893.
   PubMedGoogle Scholar
• Liesa M, Palacin M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev. 2009;89(3):799–845. doi:10.1152/physrev.00030.2008.
   PubMed Web of Science ®Google Scholar
• Frezza C, Cipolat S. Martins de Brito O, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126(1):177–89. doi:10.1016/j.cell.2006.06.025.
   PubMed Web of Science ®Google Scholar
• Landes T, Leroy I, Bertholet A, Diot A, Khosrobakhsh F, Daloyau M, Davezac N, Miquel M-C, Courilleau D, Guillou E. OPA1 (dys)functions. Semin Cell Dev Biol. 2010;21(6):593–98. doi:10.1016/j.semcdb.2009.12.012.
   PubMed Web of Science ®Google Scholar
• Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem. 2003;278(10):7743–46. doi:10.1074/jbc.C200677200.
   PubMed Web of Science ®Google Scholar
• Chen Y, Jia X, Wang P, Xiao X, Li S, Guo X, Zhang Q. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy. Mol Vis. 2013;19:292–302.
   PubMed Web of Science ®Google Scholar
• Chen J, Xu K, Zhang X, Jiang F, Liu L, Dong B, Ren Y, Li Y. Mutation screening of mitochondrial DNA as well as OPA1 and OPA3 in a Chinese cohort with suspected hereditary optic atrophy. Invest Ophthalmol & Vis Sci. 2014;55(10):6987–95. doi:10.1167/iovs.14-14953.
   PubMed Web of Science ®Google Scholar
• Wang F, Wang H, Tuan HF, Nguyen DH, Sun V, Keser V, Bowne SJ, Sullivan LS, Luo H, Zhao L, et al. Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements. Hum Genet. 2014;133(3):331–45. doi:10.1007/s00439-013-1381-5.
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England). 2009;25(14):1754–60. doi:10.1093/bioinformatics/btp324.
   PubMed Web of Science ®Google Scholar
• Ng PC, Henikoff S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812–14. doi:10.1093/nar/gkg509.
   PubMed Web of Science ®Google Scholar
• Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–49. doi:10.1038/nmeth0410-248.
   PubMed Web of Science ®Google Scholar
• Chun S, Fay JC. Identification of deleterious mutations within three human genomes. Genome Res. 2009;19(9):1553–61. doi:10.1101/gr.092619.109.
   PubMed Web of Science ®Google Scholar
• Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575–76. doi:10.1038/nmeth0810-575.
   PubMed Web of Science ®Google Scholar
• Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011;39(17):e118. doi:10.1093/nar/gkr407.
   PubMed Web of Science ®Google Scholar
• Xu M, Gelowani V, Eblimit A, Wang F, Young MP, Sawyer BL, Zhao L, Jenkins G, Creel DJ, Wang K, et al. ATF6 is mutated in early onset photoreceptor degeneration with macular involvement. Invest Ophthalmol & Vis Sci. 2015;56(6):3889–95. doi:10.1167/iovs.15-16778.
   PubMed Web of Science ®Google Scholar
• Fuhrmann N, Alavi MV, Bitoun P, Woernle S, Auburger G, Leo-Kottler B, Yu-Wai-Man P, Chinnery P, Wissinger B. Genomic rearrangements in OPA1 are frequent in patients with autosomal dominant optic atrophy. J Med Genet. 2009;46(2):136–44. doi:10.1136/jmg.2008.062570.
   PubMed Web of Science ®Google Scholar
• Almind GJ, Gronskov K, Milea D, Larsen M, Brondum-Nielsen K, Ek J. Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy. BMC Med Genet. 2011;12:49. doi:10.1186/1471-2350-12-49.
   PubMed Web of Science ®Google Scholar
• Thiselton DL, Alexander C, Taanman JW, Brooks S, Rosenberg T, Eiberg H, Andreasson S, Van Regemorter N, Munier FL, Moore AT, et al. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest Ophthalmol & Vis Sci. 2002;43(6):1715–24.
   PubMed Web of Science ®Google Scholar
• Schimpf S, Fuhrmann N, Schaich S, Wissinger B. Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons. Hum Mutat. 2008;29(1):106–12. doi:10.1002/humu.v29:1.
   PubMed Web of Science ®Google Scholar
• Kamakari S, Koutsodontis G, Tsilimbaris M, Fitsios A, Chrousos G. First report of OPA1 screening in Greek patients with autosomal dominant optic atrophy and identification of a previously undescribed OPA1 mutation. Mol Vis. 2014;20:691–703.
   PubMed Web of Science ®Google Scholar
• Hoyt CS. Autosomal dominant optic atrophy. A spectrum of disability. Ophthalmology. 1980;87(3):245–51. doi:10.1016/S0161-6420(80)35247-0.
   PubMed Web of Science ®Google Scholar
• Hamahata T, Fujimaki T, Fujiki K, Miyazaki A, Mizota A, Murakami A. OPA1 mutations in Japanese patients suspected to have autosomal dominant optic atrophy. Jpn J Ophthalmol. 2012;56(1):91–97. doi:10.1007/s10384-011-0096-1.
   PubMed Web of Science ®Google Scholar
• Votruba M, Fitzke FW, Holder GE, Carter A, Bhattacharya SS, Moore AT. Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol. 1998;116(3):351–58. doi:10.1001/archopht.116.3.351.
   PubMedGoogle Scholar
• Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46(3):145–58. doi:10.1136/jmg.2007.054270.
   PubMed Web of Science ®Google Scholar
• Votruba M, Thiselton D, Bhattacharya SS. Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy. Br J Ophthalmol. 2003;87(1):48–53. doi:10.1136/bjo.87.1.48.
   PubMed Web of Science ®Google Scholar
• Cohn AC, Toomes C, Hewitt AW, Kearns LS, Inglehearn CF, Craig JE, Mackey DA. The natural history of OPA1-related autosomal dominant optic atrophy. Br J Ophthalmol. 2008;92(10):1333–36. doi:10.1136/bjo.2007.134726.
   PubMed Web of Science ®Google Scholar
• Cohn AC, Toomes C, Potter C, Towns KV, Hewitt AW, Inglehearn CF, Craig JE, Mackey DA. Autosomal dominant optic atrophy: penetrance and expressivity in patients with OPA1 mutations. Am J Ophthalmol. 2007;143(4):656–62. doi:10.1016/j.ajo.2006.12.038.
   PubMed Web of Science ®Google Scholar
• Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, Toscano A, Musumeci O, Valentino ML, Caporali L, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010;133(3):771–86. doi:10.1093/brain/awq007.
   PubMedGoogle Scholar
• Liskova P, Ulmanova O, Tesina P, Melsova H, Diblik P, Hansikova H, Tesarova M, Votruba M. Novel OPA1 missense mutation in a family with optic atrophy and severe widespread neurological disorder. Acta Ophthalmol. 2013;91(3):e225–231. doi:10.1111/aos.2013.91.issue-3.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhang Y, Wang Y, Li W, Huang S, Chu X, Wang L, Zhang M, Liu Z. A novel OPA1 mutation responsible for autosomal dominant optic atrophy with high frequency hearing loss in a Chinese family. Am J Ophthalmol. 2007;143(1):186–88. doi:10.1016/j.ajo.2006.06.049.
   PubMed Web of Science ®Google Scholar
• Namba K, Mutai H, Takiguchi Y, Yagi H, Okuyama T, Oba S, Yamagishi R, Kaneko H, Shintani T, Kaga K, et al. Molecular impairment mechanisms of novel OPA1 mutations predicted by molecular modeling in patients with autosomal dominant optic atrophy and auditory neuropathy spectrum disorder. Otol Neurotol. 2016;37(4):394–402.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Mori N, Kishi M, Sugata H, Tsuda A, Kubota N. A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy. Am J Ophthalmol. 2003;135(2):256–57. doi:10.1016/S0002-9394(02)01929-3.
   PubMed Web of Science ®Google Scholar
• Payne M, Yang Z, Katz BJ, Warner JEA, Weight CJ, Zhao Y, Pearson ED, Treft RL, Hillman T, Kennedy RJ, et al. Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1. Am J Ophthalmol. 2004;138(5):749–55. doi:10.1016/j.ajo.2004.06.011.
   PubMed Web of Science ®Google Scholar
• Ranieri M, Del Bo R, Bordoni A, Ronchi D, Colombo I, Riboldi G, Cosi A, Servida M, Magri F, Moggio M, et al. Optic atrophy plus phenotype due to mutations in the OPA1 gene: two more Italian families. J Neurol Sci. 2012;315(1–2):146–49. doi:10.1016/j.jns.2011.12.002.
   PubMed Web of Science ®Google Scholar